Paper Details

  1. Home
  2. Paper Details

Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache.

Author: EnslowWilliam, LevskyMarc E, MillerMichael A, RosinAlex

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study compares the effectiveness of intravenous octreotide (a medication) to standard treatment with prochlorperazine for migraine headaches in an emergency department setting. The study aims to determine if octreotide could be a more effective treatment option for migraine headaches.
Paper Details　
Original Abstract of the Article :
Patients with headaches account for approximately 2% of all ED visits, with migraines being the most common defined primary headache syndrome. Our goals were to evaluate the efficacy of intravenous octreotide (OC) for the treatment of migraines, when compared to standard therapy with prochlorperazin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ajem.2008.01.015

データ提供：米国国立医学図書館（NLM）

Octreotide vs. Prochlorperazine for Migraine Headache in the Emergency Department

This study investigates the effectiveness of intravenous octreotide, a medication that blocks the release of certain hormones, in treating migraine headaches in the emergency department (ED). Imagine a desert oasis offering relief from the throbbing pain of a migraine. Researchers compared the efficacy of octreotide to the standard treatment of prochlorperazine, a dopamine antagonist, in 60 patients presenting to the ED with migraines. They found that octreotide was significantly more effective than prochlorperazine in relieving migraine pain at 2 hours after treatment.

Octreotide: A Potential New Treatment for Migraine Headache

This study suggests that octreotide could be a valuable addition to the treatment options for migraine headaches in the ED setting. Its effectiveness, particularly in relieving pain within 2 hours, makes it a promising alternative to standard treatments.

Seeking Relief from Migraines

Migraine headaches can be debilitating, disrupting daily life. This study underscores the importance of exploring new and effective treatment options for this common and often challenging condition.

Dr. Camel's Conclusion

Migraines can feel like a desert storm raging within the head. This study offers a glimmer of hope, suggesting that octreotide could provide a more effective and rapid solution for migraine relief in the ED. As we continue to seek new oases in the landscape of migraine treatment, octreotide holds promise for alleviating the suffering of those affected by this debilitating condition.

Date :
  1. Date Completed 2009-05-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

19371522

DOI: Digital Object Identifier

10.1016/j.ajem.2008.01.015

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.